John R. White Jr. Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition. Clinical Diabetes. [3]
doi.org
dx.doi.org
Chao, Edward C.; Henry, Robert R. (2010). "SGLT2 inhibition — a novel strategy for diabetes treatment". Nature Reviews Drug Discovery9 (7): 551–9. PMID20508640. doi:10.1038/nrd3180.
Tatoń, J; Piatkiewicz, P; Czech, A. (2010). "Molecular physiology of cellular glucose transport - a potential area for clinical studies in diabetes mellitus". Endokrynol Pol61 (3): 303–10. PMID20602306.
Chao, Edward C.; Henry, Robert R. (2010). "SGLT2 inhibition — a novel strategy for diabetes treatment". Nature Reviews Drug Discovery9 (7): 551–9. PMID20508640. doi:10.1038/nrd3180.
Crespy, V.; Aprikian, O.; Morand, C.; Besson, C.; Manach, C.; Demigné, C.; Rémésy, C. (2001). "Bioavailability of phloretin and phloridzin in rats". The Journal of nutrition 131 (12): 3227–3230. PMID 11739871.
Takashi Tanaka, Kazuo Yamasaki, Hiroshi Kohda, Osamu Tanaka, S. B. Mahato Dihydrochalcone-glucosides as Sweet Principles of Symplocos ssp. Planta Med 1980; 40: 81-83. doi 10.1055/s-2008-1075008 [1]Arquivado 03 de xuño de 2018 en Wayback Machine.
Takashi Tanaka, Kazuo Yamasaki, Hiroshi Kohda, Osamu Tanaka, S. B. Mahato Dihydrochalcone-glucosides as Sweet Principles of Symplocos ssp. Planta Med 1980; 40: 81-83. doi 10.1055/s-2008-1075008 [1]Arquivado 03 de xuño de 2018 en Wayback Machine.
Idris, I.; Donnelly, R. (2009). "Sodium-glucose co-transporter-2 inhibitors: An emerging new class of oral antidiabetic drug". Diabetes, Obesity and Metabolism 11 (2): 79. doi:10.1111/j.1463-1326.2008.00982.x. [2]